CMND

Clearmind Medici

• Benzinga·12h ago

  12 Health Care Stocks Moving In Friday's After-Market Session

• Benzinga·16h ago

  12 Health Care Stocks Moving In Friday's Intraday Session

• Benzinga·20h ago

  Clearmind Medicine Stock Slides Friday: What's Happening?

• TipRanks·21h ago

  Clearmind Medicine to acquire 51% stake in Charging Robotics

• Seeking Alpha·21h ago

  Clearmind Medicine signs agreement to acquire 51% stake in Charging Robotics

• Dow Jones·21h ago

  *Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Co for Automated Parking and Robotaxis

• TipRanks·1d ago

  Psychedelic: Clearmind initiates Phase IIa of CMND-100 trial

• NASDAQ·3d ago

  Clearmind Advances CMND-100 Into Phase 2a Trial For Alcohol Use Disorder; Stock Down

• TipRanks·3d ago

  Clearmind Medicine initiates next stage of CMND-100 trial for treatment of AUD

• Benzinga·3d ago

  Clearmind Medicine Initiates Phase lla, Double-Blind, Placebo-Controlled Phase I/IIa Clinical Trial Evaluating CMND-100 For Treatment Of AUD

• TipRanks·08/27 16:10

  Psychedelic: SciSparc, Clearmind publish patent application for PTSD treatment

• NASDAQ·08/24 13:30

  SciSparc Advances MDMA-PEA IP For PTSD As FDA Provides Psychedelic Drug Guidance

• TipRanks·08/24 13:20

  SciSparc, Clearmind publish U.S. patent application for MDMA-PEA combination

• NASDAQ·08/24 13:06

  Clearmind Advances MDMA-PEA Patent For PTSD Treatment Amid FDA Psychedelic Drug Guidance

• Benzinga·08/24 12:54

  SciSparc Unit Neurothera Labs And Clearmind Medicine Publish U.S. Patent Application For A Novel Combination Of 3,4-Methylenedioxymethamphetamine And N-Acylethanolamines For Use In Methods Of Treating Post-Traumatic Stress Disorder, Anxiety And Eating Disorders